Literature DB >> 8648819

TGF-beta mRNA expression in the renal pelvis after experimental and clinical ureteropelvic junction obstruction.

G M Seremetis1, M Maizels.   

Abstract

PURPOSE: The renal parenchymal expression of transforming growth factor-beta (TGF-beta) is increased in experimental obstructive uropathy. To better understand the pathophysiology of hydronephrosis, we pursued this observation by determining if the expression of TGF-beta is also increased in the obstructed renal pelvis.
MATERIALS AND METHODS: The expression of TGF-beta mRNA was evaluated in experimental and clinical ureteropelvic junction obstruction by reverse transcriptase polymerase chain reaction (RT-PCR). Southern blot analysis with labeled human cDNA probes for TGF-beta was then done to verify the results.
RESULTS: Experimentally, pelves subjected to ureteral constriction showed significantly higher TGF-beta mRNA expression than normals. After reversal of obstruction, the expression of TGF-beta remained significantly higher than normals but was not different from pelves with ongoing obstruction. Clinically, there was a significantly higher level of TGF-beta mRNA expression in obstructed pelves than in nonobstructed ureters. High levels of TGF-beta mRNA expression correlated significantly with good clinical outcome, good renal function, muscle hypertrophy and acute onset of obstruction.
CONCLUSIONS: There is increased TGF-beta mRNA expression in the renal pelvis following clinical and experimental ureteropelvic junction obstruction. These data implicate TGF-beta in the adaptive molecular responses that increase muscle and collagen elaboration seen in hydronephrosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8648819

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  8 in total

1.  The role of urinary TGF-β₁, TNF-α, IL-6 and microalbuminuria for monitoring therapy in posterior urethral valves.

Authors:  Ankur Mandelia; Minu Bajpai; Sandeep Agarwala; Arun K Gupta; Rakesh Kumar; Abid Ali
Journal:  Pediatr Nephrol       Date:  2013-06-08       Impact factor: 3.714

2.  Non-invasive markers of ureteropelvic junction obstruction.

Authors:  Stephane Decramer; Jean-Loup Bascands; Joost P Schanstra
Journal:  World J Urol       Date:  2007-08-14       Impact factor: 4.226

3.  Diuretic renography in hydronephrosis: renal tissue tracer transit predicts functional course and thereby need for surgery.

Authors:  Andreas Schlotmann; John H Clorius; Sandra N Clorius
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-05-13       Impact factor: 9.236

4.  Changes in interstitial cell of Cajal-like cells density in congenital ureteropelvic junction obstruction.

Authors:  Piotr Koleda; Wojciech Apoznanski; Zdzislaw Wozniak; Leslaw Rusiecki; Tomasz Szydelko; Witold Pilecki; Marcin Polok; Dariusz Kalka; Artur Pupka
Journal:  Int Urol Nephrol       Date:  2011-05-06       Impact factor: 2.370

Review 5.  The molecular biology of pelvi-ureteric junction obstruction.

Authors:  Laura Jackson; Mark Woodward; Richard J Coward
Journal:  Pediatr Nephrol       Date:  2017-03-13       Impact factor: 3.714

6.  Early detection of ureteropelvic junction obstruction in neonates with prenatal diagnosis of renal pelvis dilatation using 1H NMR urinary metabolomics.

Authors:  Aurélien Scalabre; Yohann Clément; Florence Guillière; Sophie Ayciriex; Ségolène Gaillard; Delphine Demède; Aurore Bouty; Pierre Lanteri; Pierre-Yves Mure
Journal:  Sci Rep       Date:  2022-08-04       Impact factor: 4.996

Review 7.  Interactions between cytokines, congenital anomalies of kidney and urinary tract and chronic kidney disease.

Authors:  Ana Cristina Simões e Silva; Flávia Cordeiro Valério; Mariana Affonso Vasconcelos; Débora Marques Miranda; Eduardo Araújo Oliveira
Journal:  Clin Dev Immunol       Date:  2013-08-26

8.  Association of urinary transforming growth factor-β1 with the ureteropelvic junction obstruction.

Authors:  Alireza Merrikhi; Emad Bahraminia
Journal:  Adv Biomed Res       Date:  2014-05-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.